Importer of Controlled Substances Application: AndersonBrecon, Inc., 55859-55860 [2021-21876]
Download as PDF
<![CDATA[
lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 86, No. 192 / Thursday, October 7, 2021 / Notices
5 CFR 1320.5, all information
collections as defined in 5 CFR 1320.3,
require approval by OMB. ONRR may
not conduct or sponsor, and you are not
required to respond to, a collection of
information unless it displays a
currently valid OMB control number.
As part of ONRR’s continuing effort to
reduce paperwork and respondent
burdens, ONRR is inviting the public
and other Federal agencies to comment
on new, proposed, revised, and
continuing collections of information in
accordance with the PRA and 5 CFR
1320.8(d)(1). This helps ONRR assess
the impact of its information collection
requirements and minimize the public’s
reporting burden. It also helps the
public understand ONRR’s information
collection requirements and provide the
requested data in the desired format.
ONRR is especially interested in
public comments addressing the
following:
(1) Whether the collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information will have practical utility;
(2) The accuracy of ONRR’s estimate
of the burden for this collection of
information, including the validity of
the methodology and assumptions used;
(3) Ways to enhance the quality,
utility, and clarity of the information to
be collected; and
(4) How might the agency minimize
the burden of the collection of
information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology, e.g., permitting
electronic submission of response.
ONRR published a notice, with a 60day public comment period soliciting
comment of this collection of
information, in the Federal Register on
April 21, 2021 (86 FR 20710). ONRR
received no comments from companies
regarding the published 60-day Federal
Register notice.
Comments that you submit in
response to this 30-day notice are a
matter of public record. ONRR will
include or summarize each comment in
its request to OMB to approve this ICR.
Before including your address, phone
number, email address, or other
personal identifying information in your
comment, you should be aware that
your entire comment—including your
personal identifying information—may
be made publicly available at any time.
While you can ask ONRR in your
comment to withhold information from
public review, ONRR cannot guarantee
that it will be able to do so.
VerDate Sep<11>2014
17:46 Oct 06, 2021
Jkt 256001
Abstract: (a) General Information: The
Federal Oil and Gas Royalty
Management Act of 1982 (‘‘FOGRMA’’)
directs the Secretary of the Interior
(‘‘Secretary’’) to maintain a
comprehensive inspection, collection,
and fiscal and production accounting
and auditing system that: (1) Accurately
determines mineral royalties, interest,
and other payments owed, (2) collects
and accounts for such amounts in a
timely manner, and (3) disburses the
funds collected. See 30 U.S.C. 1701 and
1711. ONRR performs these mineral
revenue management responsibilities for
the Secretary. See Secretarial Order No.
3306. Royalty payors submit royalty
reports to ONRR on a monthly basis by
submitting form ONRR–2014 (Report of
Sales and Royalty Remittance reported
in OMB Control Number 1012–0004),
and form ONRR–4430 (Solid Minerals
Production and Royalty Report reported
in OMB Control Number 1012–0010).
These forms result in accounts
receivables and capture most of the
mineral revenues that ONRR collects.
(b) Information Collections: Every
year, under the Chief Financial Officers
Act of 1990 (‘‘CFO Act’’), the OIG or its
agent audits the accounts receivable
portions of the Department of the
Interior’s financial statements, which
includes ONRR accounts receivable. As
part of the audit, the OIG or its agent
randomly selects a sample of ONRR
accounts receivable. For each one
selected, ONRR generates an accounts
receivable confirmation letter to the
royalty payor to obtain third-party
confirmation of the validity of the
financial record for the audit. In order
to meet the CFO Act’s requirements, the
letter must be on ONRR letterhead and
the Deputy Director for ONRR, or his or
her designee, must sign the letter. The
letter requests a response by a specified
date to verify: (1) Customer
identification; (2) royalty invoice
number; (3) payor assigned document
number; (4) date of ONRR’s receipt; (5)
original amount the payor reported; and
(6) remaining balance due to ONRR. The
OIG or its agent mails the letter to the
payor and instructs it to respond
directly to the OIG or its agent. The
information provided helps ensure that
ONRR’s financial records are accurate.
Title of Collections: Accounts
Receivable Confirmations Reporting.
OMB Control Number: 1012–0001.
Form(s) Number: None.
Type of Review: Extension of a
currently approved collection.
Respondent/Affected Public:
Businesses.
Total Estimated Number of Annual
Respondents: 24 randomly-selected
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
55859
mineral payors from Federal and Indian
lands and the Outer Continental Shelf.
Total Estimated Number of Annual
Responses: 24.
Estimated Completion Time per
Response: ONRR estimates that each
response will take 15 minutes for the
payor to complete.
Total Estimated Number of Annual
Burden Hours: 6 hours.
Respondent’s Obligation: Voluntary.
Frequency of Collection: Annual.
Total Estimated Annual Non-hour
Burden Cost: ONRR did not identify any
‘‘non-hour cost’’ burden associated with
this collection of information.
An agency may not conduct or
sponsor, and a person is not required to
respond to, a collection of information
unless it displays a currently valid OMB
control number.
The authority for this action is the
PRA (44 U.S.C. 3501 et seq).
Kimbra G. Davis,
Director, Office of Natural Resources
Revenue.
[FR Doc. 2021–21893 Filed 10–6–21; 8:45 am]
BILLING CODE 4335–30–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–905]
Importer of Controlled Substances
Application: AndersonBrecon, Inc.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
AndersonBrecon, Inc. has
applied to be registered as an importer
of basic class(es) of controlled
substance(s). Refer to Supplemental
Information listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before November 8, 2021. Such
persons may also file a written request
for a hearing on the application on or
before November 8, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for a hearing
should also be sent to: (1) Drug
SUMMARY:
E:\FR\FM\07OCN1.SGM
07OCN1
55860
Federal Register / Vol. 86, No. 192 / Thursday, October 7, 2021 / Notices
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on May 19, 2021,
AndersonBrecon, Inc., 4545 Assembly
Drive, Rockford, Illonois 61109, applied
to be registered as an importer of the
following basic class(es) of controlled
substance(s):
Controlled substance
Tetrahydrocannabinols ...
Drug
code
Schedule
7370
I
The company plans to import the
listed controlled substance for clinical
trials only. Approval of permit
applications will occur only when the
registrant’s business activity is
consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization
will not extend to the import of Food
and Drug Administration-approved or
non-approved finished dosage forms for
commercial sale.
Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021–21876 Filed 10–6–21; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–906]
Importer of Controlled Substances
Application: Caligor Coghlan Pharma
Services
Drug
code
Controlled substance
Tapentadol ......................
I
9780
Schedule
III
The company plans to import the
listed controlled substance in finished
dosage form to be used in pediatric
clinical trials. No other activity for this
drug code is authorized for this
registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Brian S. Besser,
Acting Assistant Administrator.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
[FR Doc. 2021–21878 Filed 10–6–21; 8:45 am]
Caligor Coghlan Pharma
Services has applied to be registered as
an importer of basic class(es) of
controlled substance(s). Refer to
Supplemental Information listed below
for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before November 8, 2021. Such
persons may also file a written request
for a hearing on the application on or
before November 8, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
DEPARTMENT OF JUSTICE
AGENCY:
SUMMARY:
lotter on DSK11XQN23PROD with NOTICES1
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on August 16, 2021,
Caligor Coghlan Pharma Services, 1500
Business Park Drive, Unit B, Bastrop,
Texas 78602, applied to be registered as
an importer of the following basic
class(es) of controlled substance(s):
VerDate Sep<11>2014
17:46 Oct 06, 2021
Jkt 256001
BILLING CODE P
Drug Enforcement Administration
[Docket No. DEA–907]
Bulk Manufacturer of Controlled
Substances Application: Bulk
Manufacturer of Marihuana: New
Mexico Top Organics-Ultra Health
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
The Drug Enforcement
Administration (DEA) is providing
notice of an application it has received
from an entity applying to be registered
SUMMARY:
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
to manufacture in bulk basic class(es) of
controlled substances listed in schedule
I. DEA intends to evaluate this and other
pending applications according to its
regulations governing the program of
growing marihuana for scientific and
medical research under DEA
registration.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefor, may file written
comments on or objections to the
issuance of the proposed registration on
or before December 6, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW 8701
Morrissette Drive, Springfield, Virginia
22152. To ensure proper handling of
comments, please reference Docket
No—DEA–907 in all correspondence,
including attachments.
SUPPLEMENTARY INFORMATION: The
Controlled Substances Act (CSA)
prohibits the cultivation and
distribution of marihuana except by
persons who are registered under the
CSA to do so for lawful purposes. In
accordance with the purposes specified
in 21 CFR 1301.33(a), DEA is providing
notice that the entity identified below
has applied for registration as a bulk
manufacturer of schedule I controlled
substances. In response, registered bulk
manufacturers of the affected basic
class(es), and applicants therefor, may
file written comments on or objections
of the requested registration, as
provided in this notice. This notice does
not constitute any evaluation or
determination of the merits of the
application submitted.
The applicant plans to manufacture
bulk active pharmaceutical ingredients
(APIs) for product development and
distribution to DEA-registered
researchers. If the application for
registration is granted, the registrant
would not be authorized to conduct
other activity under this registration
aside from those coincident activities
specifically authorized by DEA
regulations. DEA will evaluate the
application for registration as a bulk
manufacturer for compliance with all
applicable laws, treaties, and
regulations and to ensure adequate
safeguards against diversion are in
place.
As this applicant has applied to
become registered as a bulk
manufacturer of marihuana, the
application will be evaluated under the
criteria of 21 U.S.C. 823(a). DEA will
conduct this evaluation in the manner
described in the rule published at 85 FR
82333 on December 18, 2020, and
E:\FR\FM\07OCN1.SGM
07OCN1
]]>Agencies
[Federal Register Volume 86, Number 192 (Thursday, October 7, 2021)]
[Notices]
[Pages 55859-55860]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-21876]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-905]
Importer of Controlled Substances Application: AndersonBrecon,
Inc.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: AndersonBrecon, Inc. has applied to be registered as an
importer of basic class(es) of controlled substance(s). Refer to
Supplemental Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before November 8,
2021. Such persons may also file a written request for a hearing on the
application on or before November 8, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
request for a hearing should also be sent to: (1) Drug
[[Page 55860]]
Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on May 19, 2021, AndersonBrecon, Inc., 4545 Assembly
Drive, Rockford, Illonois 61109, applied to be registered as an
importer of the following basic class(es) of controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols.................. 7370 I
------------------------------------------------------------------------
The company plans to import the listed controlled substance for
clinical trials only. Approval of permit applications will occur only
when the registrant's business activity is consistent with what is
authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to
the import of Food and Drug Administration-approved or non-approved
finished dosage forms for commercial sale.
Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021-21876 Filed 10-6-21; 8:45 am]
BILLING CODE 4410-09-P
